BOSTON, MA / ACCESSWIRE / August 19, 2020 / AG Mednet, a technology company streamlining, automating and increasing data quality for clinical trials, has named Brian Zabin as COO. In his new position, Zabin will help continue AG Mednet's strong momentum in furthering clinical trial workflow and automation through adoption of Judi, the company's clinical trial technology platform. He will play a crucial role in driving key operational and financial performance measures while advancing the company's long-term strategy by developing new areas for growth, pursuing key strategic partnerships and leading AG Mednet's drive to develop solutions for unmet areas of data quality needs and workflow inefficiencies in the industry.
Zabin is a returning member of AG Mednet's original team, having served as Vice President, Business Development from 2007 to 2009. At that time, Zabin led the implementation of the company's strategy and investment in the clinical trials market.
Zabin, an MIT Sloan School of Management graduate, most recently served as a diplomat in various countries for the U.S. Department of State, worked for Boston Consulting Group in the Health Care practice in Boston and Zurich, and is a former Captain in the United States Marine Corps.
Numed, a well established company in business since 1975 provides a wide range of service options including time & material service, PM only contracts, full service contracts, labor only contracts & system relocation. Call 800 96 Numed for more info.
"AG Mednet is on an industry-wide rapid growth trajectory, and that path is accelerating across all facets of the clinical trials industry," said Abraham Gutman, founder and CEO of AG Mednet. "For the past 25 years, Brian has served in various leadership positions across the military, business and international trade and diplomacy. There is no one more capable of working with me and leading AG Mednet's strategic growth than Brian."
About AG Mednet
AG Mednet is the leading quality compliance partner for image data management, DSMB, endpoint and adverse event adjudication workflows. The company is a proponent of zero-delay clinical trials. The company has supported more than 1,800 global clinical trials. Hundreds of adjudication protocols are being managed by sponsors and CROs using Judi. More than 70,000 registered users across thousands of investigator sites in more than 80 countries use AG Mednet to submit more than 20,000,000 images per month and adjudicate thousands of events in projects sponsored by each of the world's top 20 pharmaceutical, biotech and medical device companies. Learn more at www.agmednet.com.